Forward Price-to-Revenue Multiple: Select Medical Corporation (SEM)

Graphic logo of Select Medical Holdings (SEM)

The resilience of Select Medical (SEM) to crises is confirmed by the projected P/S ratio, where 0.40 determines this parameter level. Stable demand for health recovery minimizes the impact of economic cycles. Effective personnel management reduces the risk of medical staff burnout. A closed-loop referral system from hospitals and an aging population ensure growth, despite regulatory pressure on Medicare tariffs.

SEM (Select Medical Holdings) Forward Price to Sales history from 07/04/2022 to 07/11/2026

SEM (Select Medical Inc.): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Select Medical Holdings|SEM - Consensus Target
- company stock exchange capitalization indicators:
Market Valuation Select Medical Inc.|SEM - Aggregate Business Value
- business book valuation details:
Accounting Value per Share Select Medical|SEM - Accounting Value of Company|Market Value to Book Value Ratio selectmedical.com|SEM - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Select Medical|SEM - Long-Term Liabilities to Capital|Short-Term Debt to Capital Select Medical|SEM - Company Aggregate Debt|Debts to Book Capitalization Select Medical Inc.|SEM - Long-Term Debt Volume|Company Short-Term Debts Select Medical|Quick Ratio selectmedical.com
- net income and valuation multiples indicators:
SEM - Net Profit|Expected Profit Select Medical|SEM - Price to Earnings Ratio|Future Price to Earnings Select Medical Corp|SEM - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Select Medical Inc.|SEM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Select Medical|SEM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months selectmedical.com|SEM - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Select Medical
- company sales and revenue statistics:
SEM - Company Sales Revenue|Projected Sales Volume Select Medical Holdings|SEM - Price to Sales|Forward P/S Multiple Select Medical Inc.
Fundamental company valuation:Select Medical Holdings SEM
Product sample of Select Medical Inc.

The forward P/S ratio reflects the company's valuation relative to its projected revenue, allowing for an assessment of the premium paid for future income streams. Investors analyze this metric to determine the balance between expansion rates and the market value of assets. The trend of the forward P/S ratio visualizes market expectations regarding business efficiency. For Select Medical (SEM), this indicator confirms confidence in an experienced management team that is optimizing value through the sale of non-core units.

Analysis of competing companies

Forward P/S Multiple HCA (HCA Healthcare)|THC - Forward Price-to-Revenue Multiple|FMS: Forward Price-to-Revenue Multiple|Solventum Health - Price to Expected Revenue Ratio|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|Universal Health Services, Inc. - Forward Price to Sales|Price-to-Projected Revenue Ratio DaVita|Forward Price-to-Revenue Multiple RadNet Inc (RDNT)|Forward P/S Multiple OPCH|SGRY - Market Cap to Future Revenue Ratio|Forward P/S Multiple PINC (Premier, Inc.)|EYE: Market Cap to Projected Revenue|Progyny - Forward P/S Multiple|Market Cap to Expected Sales Ratio Ardent Health ARDT|ASTH: Forward P/S Multiple|Forward Price-to-Revenue Multiple MEDNAX|USPH (US Physical Therapy) - Forward P/S Multiple|Forward P/S Multiple pennantgroup.com|Price-to-Projected Revenue Ratio Organogenesis (ORGO)|Price-to-Projected Revenue Ratio NUTX (Nutex Health Inc)|Price-to-Projected Revenue Ratio Auna Health AUNA|Market Cap to Expected Sales Ratio SBC Medical Group Holdings (SBC)|Evolus, Inc. - Forward P/S Multiple|Market Cap to Future Revenue Ratio chs.net|beautyhealth.com (SKIN) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple MediWound|Forward Price-to-Revenue Multiple BTMD|JYNT (The Joint) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio DocGo Inc. (DCGO)|PIII (p3hp.org) - Forward Price to Sales|Forward P/S Multiple GANX (Gain Therapeutics)|EUDA Health Holdings (EUDA) - Market Cap to Future Revenue Ratio|Basel Medical Group Limited - Forward P/S Multiple|CLGN - Forward P/S Multiple|CUPR (Cuprina Holdings (Cayman) Ltd) - Forward Price-to-Revenue Multiple|CCM: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio American Shared Hospital Services|Forward Price-to-Revenue Multiple MEDIROM Healthcare Group Inc. (MRM)|Forward P/S Multiple ALBT|DHAI - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Inc. - Price to Expected Revenue Ratio|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|MODV - Market Cap to Expected Sales Ratio|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Market Cap to Future Revenue Ratio SunLink Health Systems, Inc SSY|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)